Atlas Trials

German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa

Clinical trial NCT06095713 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06095713
Sponsor
Universität Münster
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Fabry Disease
Start date
2023-10-01
Primary completion
2027-09-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.